このページの翻訳は実験的なもので、現在開発中です。お待ちしております
LifeTech Scientific バランスシートの健全性
財務の健全性 基準チェック /66
LifeTech Scientificの総株主資本はCN¥3.3B 、総負債はCN¥0.0で、負債比率は0%となります。総資産と総負債はそれぞれCN¥4.7BとCN¥1.4Bです。 LifeTech Scientificの EBIT はCN¥328.5Mで、利息カバレッジ比率-27.2です。現金および短期投資はCN¥1.2Bです。
主要情報
2.9%
負債資本比率
CN¥99.00m
負債
| インタレスト・カバレッジ・レシオ | -16x |
| 現金 | CN¥1.04b |
| エクイティ | CN¥3.39b |
| 負債合計 | CN¥1.43b |
| 総資産 | CN¥4.82b |
財務の健全性に関する最新情報
Is LifeTech Scientific (HKG:1302) A Risky Investment?
Nov 20
LifeTech Scientific (HKG:1302) Could Easily Take On More Debt
Mar 31Recent updates
Some Confidence Is Lacking In LifeTech Scientific Corporation's (HKG:1302) P/E
Jul 05LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear
Apr 25What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You
Dec 25Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled
Nov 28At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?
Nov 03Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
Aug 17Is There Now An Opportunity In LifeTech Scientific Corporation (HKG:1302)?
Jul 18Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
May 05Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return
Oct 14There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital
Jul 15Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?
Jun 30A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)
Jun 15Returns At LifeTech Scientific (HKG:1302) Are On The Way Up
Apr 03Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
Mar 15Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?
Jan 22Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital
Dec 19Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today
Dec 06Is LifeTech Scientific (HKG:1302) A Risky Investment?
Nov 20An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued
Oct 12The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence
Sep 13Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?
Aug 28What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?
Aug 13LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business
Jun 08Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
May 26Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?
May 11LifeTech Scientific (HKG:1302) Could Easily Take On More Debt
Mar 31Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%
Feb 21Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?
Jan 26Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 13
Are Strong Financial Prospects The Force That Is Driving The Momentum In LifeTech Scientific Corporation's HKG:1302) Stock?
Nov 25財務状況分析
短期負債: 1302の 短期資産 ( CN¥2.2B ) が 短期負債 ( CN¥770.1M ) を超えています。
長期負債: 1302の短期資産 ( CN¥2.2B ) が 長期負債 ( CN¥602.3M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: 1302総負債よりも多くの現金を保有しています。
負債の削減: 1302の負債対資本比率は、過去 5 年間で22.7%から2.9%に減少しました。
債務返済能力: 1302の負債は 営業キャッシュフロー によって 十分にカバー されています ( 422.3% )。
インタレストカバレッジ: 1302支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。